Aurobindo Pharma has informed that it is attending investor conference on 27th and 28th March, 2019 hosted by Credit Suisse in Hong Kong. The attached presentation will be used in the aforesaid investor conference. The presentation is also being uploaded on the website of the Company - https://www.aurobindo.com/investors/results-reports-presentations/investor-presentations/
The above information is a part of company’s filings submitted to BSE.